NDC 0591-2136-55 - Propofol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0591-2136
- Requested NDC
- 0591-2136-55
- Package NDCs from labels
- 0591-2136-55, 0591-2136-51, 0591-2136-57, 0591-2136-68, 0591-2136-80, 0591-2136-95
- Manufacturer
- Actavis Pharma, Inc.
- Effective date
- 2023-05-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Propofol - Actavis Pharma, Inc. | Actavis Pharma, Inc. | 2023-05-30 | HUMAN PRESCRIPTION DRUG LABEL |
| PROPOFOL - Henry Schein, Inc. | Henry Schein, Inc. | 2022-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
| PROPOFOL - General Injectables & Vaccines, Inc. | General Injectables & Vaccines, Inc. | 2021-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Propofol - A-S Medication Solutions | A-S Medication Solutions | 2021-04-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Propofol | General Injectables and Vaccines, Inc. | 2018-04-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0591-2136-51 | ML - Milliliter | 0591-2136 | 0b14f2f2-28a4-4fb5-a669-08abd4efc03a | 1 | 2016-02-04 |
| 0591-2136-55 | ML - Milliliter | 0591-2136 | c7340b05-171e-42b9-9aaa-f4423b6cba5b | 1 | 2016-02-04 |
| 0591-2136-57 | ML - Milliliter | 0591-2136 | 20f74f85-7313-40e5-a1bd-99d35d50d3cd | 1 | 2016-02-04 |
| 0591-2136-68 | ML - Milliliter | 0591-2136 | 47d8a6dd-b9a7-457a-a1e8-e8e835d9157a | 1 | 2016-02-04 |
| 0591-2136-80 | ML - Milliliter | 0591-2136 | ecc8f542-06b4-4ab8-8638-70de2da9f8bd | 1 | 2016-02-04 |
| 0591-2136-95 | ML - Milliliter | 0591-2136 | 0d8814c1-098b-4f9e-8b00-4e25f3db5dc8 | 1 | 2016-02-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anubis Barcelona | PROTEOGLYCAN, GLYCERIN, BUTYLENE GLYCOL | ANUBIS COSMETICS SL | ebdddcec-f5da-51fe-e053-2995a90a6167 | 2023-09-01 | Warnings | PDC6A3C0OX |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, PANTHENOL, THIAMINE HCL | ANUBIS COSMETICS SL | eb8e5beb-4452-58c2-e053-2a95a90a66e0 | 2023-09-01 | Warnings | PDC6A3C0OX |
| Anubis Barcelona Protective Line | ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL SALICYLATE, OCTOCRYLENE | ANUBIS COSMETICS SL | ec83846f-11c0-8f59-e053-2995a90ab9d2 | 2023-09-01 | Warnings | PDC6A3C0OX |
| Anubis Barcelona Regul Oil | CETEARYL ETHYLHEXANOATE, PROPYLENE GLYCOL, GLYCERYL STEARATE SE | ANUBIS COSMETICS SL | eb68c3ab-7835-1a1c-e053-2995a90a0d66 | 2023-09-01 | Warnings | PDC6A3C0OX |
| Anubis Barcelona | PROPANEDIOL, GLYCERIN, MAGNESIUM ASCORBYL PHOSPHATE | ANUBIS COSMETICS SL | eb53cba1-0509-43bc-e053-2995a90a5e09 | 2023-09-01 | Warnings | PDC6A3C0OX |
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | PDC6A3C0OX |
| Anubis Barcelona | FERULIC ACID, VITAMIN C, DMAE | ANUBIS COSMETICS SL | eaf0770c-795d-0232-e053-2a95a90ae0b5 | 2023-09-01 | Warnings | PDC6A3C0OX |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, GLYCERYL STEARATE SE, HUMULUS LUPULUS (HOPS) CONE EXTRACT | ANUBIS COSMETICS SL | eb7c418b-8bee-26a3-e053-2a95a90a4e96 | 2023-09-01 | Warnings | PDC6A3C0OX |
| Anubis Barcelona Total Hydrating | BETAINE, GLYCERIN, POLYSORBATE 20 | ANUBIS COSMETICS SL | eaefe3b9-9064-18b1-e053-2a95a90a5765 | 2023-09-01 | Warnings | PDC6A3C0OX |
| Anubis Barcelona Vital Line | HYDROLYZED COLLAGEN | ANUBIS COSMETICS SL | f564bbf0-3b5c-4a81-e053-2a95a90a7ea6 | 2023-08-29 | Warnings | PDC6A3C0OX |
| SODIUM PHENYLACETATE AND SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | MAIA PHARMACEUTICALS, INC | 3529be10-0004-4628-9ca1-67a8acd86b51 | 2023-07-05 | Warnings, Adverse reactions | OJ245FE5EU |
| c7c244bb-7111-4351-a4e9-c995406729d1 | 6f8bebf9-d87b-469a-911a-21135ba841ae | 2023-05-30 | Warnings, Adverse reactions | c7c244bb-7111-4351-a4e9-c995406729d1 6f8bebf9-d87b-469a-911a-21135ba841ae | ||
| Virility Liquescence | AVENA SATIVA, DAMIANA, BERBERIS VULGARIS, EPIMEDIUM GRANDIFLORUM, GLYCERINUM, SABAL SERRULATA, IODIUM, LECITHIN, FERRUM MURIATICUM, NATRUM MURIATICUM, AGNUS CASTUS, BUFO RANA, CINCHONA OFFICINALIS, HUMAN GROWTH HORMONE (HGH), ORCHITINUM (BOVINE), PHOSPHORICUM ACIDUM, PHOSPHORUS, SELENIUM METALLICUM, ZINCUM VALERIANICUM, OOPHORINUM (SUIS), SEPIA | Nutritional Specialties, Inc. | 81cc3e2b-f95e-4ba4-a15f-c07b4def0e2f | 2023-03-29 | Warnings | PDC6A3C0OX 1Z74184RGV |
| Metabolic Correction Blend | FOENICULUM VULGARE, AMMONIUM BROMATUM, FUCUS VESICULOSUS, LECITHIN (DERIVED FROM EGG), CAPSICUM ANNUUM, GALIUM APARINE, HYPOTHALAMUS SUIS, KALI BICHROMICUM, LAC DEFLORATUM (NSPC), PHYTOLACCA DECANDRA, PROGESTERONE, THYROIDINUM (BOVINE), PITUITARUM POSTERIUM (BOVINE), ANTIMONIUM CRUDUM, ARGENTUM METALLICUM, CALCAREA CARBONICA, FERRUM METALLICUM, GRAPHITES, ADRENALINUM, PHOSPHORUS | IHA Distribution, LLC | e8ec4f7e-c9dd-46dd-a9ee-2b8b7bcea9a8 | 2023-03-21 | Warnings | 1Z74184RGV |
| Sodium Phenylacetate and Sodium Benzoate | SODIUM PHENYLACETATE AND SODIUM BENZOATE | MAIA PHARMACEUTICALS | ab40b62b-9f8d-4394-92d5-09d9f1941eaa | 2023-01-16 | Warnings, Adverse reactions | OJ245FE5EU |
| e4b658b2-b027-4a54-b0da-d8d60343e041 | 16dd86f5-1425-4fd3-9c5c-960ff49ca14b | 2022-12-30 | Warnings, Adverse reactions | 16dd86f5-1425-4fd3-9c5c-960ff49ca14b | ||
| fc30b3ed-b630-4a1d-a42a-15fd302151e0 | 008eb28a-6a54-479f-9530-273b8376f764 | 2022-12-29 | Warnings, Adverse reactions | 008eb28a-6a54-479f-9530-273b8376f764 | ||
| PROPOFOL | PROPOFOL | HF Acquisition Co LLC, DBA HealthFirst | 7b9599e0-5bad-742d-e053-2991aa0aee97 | 2022-12-09 | Warnings, Adverse reactions | YI7VU623SF |
| Refresh Digital PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | 97e83e68-6374-4df4-93f6-d707fc32748d | 2022-11-28 | Warnings | PDC6A3C0OX |
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.